Longeveron (LGVN) EBIT Margin (2020 - 2026)
Longeveron (LGVN) posted quarterly EBIT Margin of 1199.75% for Q1 2026, up 16009.0% year-over-year from N/an in Q1 2025, and up 18.89% quarter-over-quarter from 1479.18% in Q4 2025.
Longeveron (LGVN) EBIT Margin (2020 - 2026) Analysis & Trends
Longeveron's EBIT Margin history runs 7 years deep, the most recent figure standing at 1199.75% for Q1 2026.
- In Q1 2026, EBIT Margin rose 16009.0% year-over-year to 1199.75%; the TTM figure through Mar 2026 stood at 1881.66% (down 109016.0% YoY), while the FY2025 annual figure was 1942.2%, down 125148.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 1199.75%, up from 1479.18% in the prior quarter.
- The five-year high for EBIT Margin was 601.42% in Q3 2024, with the low at 8634.92% in Q4 2023.
- The 5-year median for EBIT Margin is 1479.18% (2025), against an average of 2459.13%.
- The sharpest annual moves came in 2024 and 2025: EBIT Margin surged 792497 bps in 2024, then sank 473434 bps in 2025.
- Longeveron's EBIT Margin stood at 4331.4% in 2022, then sank by 99 bps to 8634.92% in 2023, then soared by 92 bps to 709.95% in 2024, then slumped by 108 bps to 1479.18% in 2025, then advanced by 19 bps to 1199.75% in 2026.
- Business Quant data shows LGVN's EBIT Margin at 1199.75% in Q1 2026, 1479.18% in Q4 2025, and 5335.77% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.75% |
| 10 | Longeveron | 26.51 Mn | 16.41 Mn | 182,000.00 | -2,150.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,150.17% |
| Mar 31, 2026 | -1,199.75% |
| Dec 31, 2025 | -1,479.18% |
| Sep 30, 2025 | -5,335.77% |
| Jun 30, 2025 | -1,707.91% |
| Mar 31, 2025 | -1,359.84% |
| Dec 31, 2024 | -709.95% |
| Sep 30, 2024 | -601.42% |
| Jun 30, 2024 | -747.86% |
| Mar 31, 2024 | -746.35% |
| Dec 31, 2023 | -8,634.92% |
| Sep 30, 2023 | -3,440.67% |
| Jun 30, 2023 | -2,632.26% |
| Mar 31, 2023 | -1,690.32% |
| Dec 31, 2022 | -4,331.40% |
| Sep 30, 2022 | -5,187.00% |
| Jun 30, 2022 | -905.79% |
| Mar 31, 2022 | -1,094.84% |
| Dec 31, 2021 | -1,929.19% |
| Sep 30, 2021 | -2,114.22% |